Cargando…

Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA Vectors

DNA vaccines with their extraordinary properties are the best choice as vectors for subunit vaccines but are not in compliance with safety regulations, mainly because of the antibiotic resistance genes on their backbone. New generations of plasmids with minimum bacterial backbones are now developed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seyed, Negar, Zahedifard, Farnaz, Habibzadeh, Sima, Yousefi, Roya, Lajevardi, Mahya Sadat, Gholami, Elham, Rafati, Sima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611672/ https://www.ncbi.nlm.nih.gov/pubmed/36298575 http://dx.doi.org/10.3390/vaccines10101710

Ejemplares similares

Leishmania tarentolae as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice Model
por: Lajevardi, Mahya Sadat, et al.
Publicado: (2022)

Structural analysis of PpSP15 and PsSP9 sand fly salivary proteins designed with a self-cleavable linker as a live vaccine candidate against cutaneous leishmaniasis
por: Lajevardi, Mahya Sadat, et al.
Publicado: (2022)

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy
por: Taslimi, Yasaman, et al.
Publicado: (2016)

Leishmania Parasite: the Impact of New Serum-Free Medium as an Alternative for Fetal Bovine Serum
por: Habibzadeh, Sima, et al.
Publicado: (2021)

Isolation, characterization, and functional study of extracellular vesicles derived from Leishmania tarentolae
por: Shokouhy, Mehrdad, et al.
Publicado: (2022)

Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials
por: Zahedifard, Farnaz, et al.
Publicado: (2019)

Correction: Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials
por: Zahedifard, Farnaz, et al.
Publicado: (2019)

Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
por: Zahedifard, Farnaz, et al.
Publicado: (2014)

In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response
por: Seyed, Negar, et al.
Publicado: (2011)

Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors
por: Williams, James A., et al.
Publicado: (2023)

Human Neutrophil Peptide-1 (HNP-1): A New Anti-Leishmanial Drug Candidate
por: Dabirian, Sara, et al.
Publicado: (2013)

Visualization of Leishmania tropica Infection in BALB/c Mice by Bioluminescence Imaging
por: Eskandar, Mahdieh, et al.
Publicado: (2020)

Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice
por: Abdossamadi, Zahra, et al.
Publicado: (2017)

Novel strategy using live non-pathogenic Leishmania expressing selected parasite antigens as a candidate vaccine for leishmaniasis
por: Rafati, Sima, et al.
Publicado: (2011)

Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB(-CTE) Antigens against Visceral Leishmaniasis in Syrian Hamster as Preliminary Study
por: TASLIMI, Yasaman, et al.
Publicado: (2020)

Post-Genomics and Vaccine Improvement for Leishmania
por: Seyed, Negar, et al.
Publicado: (2016)

Nanoplasmid Vectors Co-expressing Innate Immune Agonists Enhance DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus
por: Suschak, John J., et al.
Publicado: (2020)

Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Leishmania
por: Seyed, Negar, et al.
Publicado: (2018)

Optimization of the Timing of Induction for the Assessment of Nitric Oxide Production in Leishmania major Infected Macrophage Cells
por: SADEGHI, Somaye, et al.
Publicado: (2016)

C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice
por: Doroud, Delaram, et al.
Publicado: (2011)

DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica
por: Gholami, Elham, et al.
Publicado: (2019)

Correction: DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica
por: Gholami, Elham, et al.
Publicado: (2019)

Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice
por: Davarpanah, Elaheh, et al.
Publicado: (2020)

In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite
por: Sadeghi, Somayeh, et al.
Publicado: (2015)

Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis
por: Shahbazi, Mehdi, et al.
Publicado: (2015)

A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis
por: Taslimi, Yasaman, et al.
Publicado: (2017)

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2013)

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites
por: Badirzadeh, Alireza, et al.
Publicado: (2017)

Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica
por: Masoudzadeh, Nasrin, et al.
Publicado: (2020)

CD8(+) T Cells in Leishmania Infections: Friends or Foes?
por: Stäger, Simona, et al.
Publicado: (2012)

Possible Diagnostic Improvement for Cutaneous Leishmaniasis: Is It Achievable?
por: Taslimi, Yasaman, et al.
Publicado: (2018)

Tape-disc-loop-mediated isothermal amplification (TD-LAMP) method as noninvasive approach for diagnosis of cutaneous leishmaniasis caused by L. tropica
por: Taslimi, Yasaman, et al.
Publicado: (2023)

DNA Immunization as an Efficient Strategy for Vaccination
por: Bolhassani, Azam, et al.
Publicado: (2009)

Enhancement of potent immune responses to HPV16 E7 antigen by using different vaccine modalities
por: Bolhassani, Azam, et al.
Publicado: (2011)

Conventional, molecular methods and biomarkers molecules in detection of septicemia
por: Arabestani, Mohammad Reza, et al.
Publicado: (2015)

Improvement of different vaccine delivery systems for cancer therapy
por: Bolhassani, Azam, et al.
Publicado: (2011)

Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2014)

Study of Out-of-Pocket Expenditures for Outpatient Imaging Services in Imam-Khomeini Hospital in 2014
por: Marzban, Sima, et al.
Publicado: (2015)

Biomarkers of Cutaneous Leishmaniasis
por: Bahrami, Fariborz, et al.
Publicado: (2018)

Comparison of marginal and internal adaptation of provisional polymethyl methacrylate restorations fabricated by two three-dimensional printers: An in vitro study
por: Hasanzade, Mahya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_259g0571ri4dh4io9oaetnvkni